Cargando…
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS:...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261591/ https://www.ncbi.nlm.nih.gov/pubmed/25267108 http://dx.doi.org/10.1186/1471-2334-14-523 |
_version_ | 1782348300222988288 |
---|---|
author | Fang, Wei-Jia Jing, Da-Zhi Luo, Yun Fu, Cai-Yun Zhao, Peng Qian, Jiong Tian, Bing-Ru Chen, Xiao-Gang Zheng, Yu-Long Zheng, Yi Deng, Jing Zou, Wei-Hua Feng, Xue-Ren Liu, Fan-Long Mou, Xiao-Zhou Zheng, Shu-Sen |
author_facet | Fang, Wei-Jia Jing, Da-Zhi Luo, Yun Fu, Cai-Yun Zhao, Peng Qian, Jiong Tian, Bing-Ru Chen, Xiao-Gang Zheng, Yu-Long Zheng, Yi Deng, Jing Zou, Wei-Hua Feng, Xue-Ren Liu, Fan-Long Mou, Xiao-Zhou Zheng, Shu-Sen |
author_sort | Fang, Wei-Jia |
collection | PubMed |
description | BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS: A total of 400 stool samples were collected from cancer patients who received chemotherapy in three hospitals of eastern China. Bacterial genomic DNA was extracted and two toxin genes (tcdA and tcdB) were detected. PCR ribotyping was performed using capillary gel electrophoresis. Concentrations of prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β) and interleukin-10 (IL-10) were measured using enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: Eighty-two (20.5%) samples were confirmed to be C. difficile-positive and positive for tpi, tcdA, and tcdB genes. The C. difficile-positive rates in patients with diarrhea and no diarrhea were 35% and 19.7%, respectively (p = 0.09). Patients who were younger than 50 years old and were hospitalized for at least 10 days had a C. difficile-positive rate as high as 35%. In contrast, patients who were older than 50 years old and were hospitalized for less than 10 days had a C. difficile-positive rate of only 12.7% (p = 0.0009). No association was found between C. difficile carriage and chemotherapy regimen, antibiotic drug use, or immunosuppressive mediators, such as prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β), or interleukin-10 (IL-10). Twelve ribotypes of C. difficile were identified, but none of them belonged to ribotype 027. CONCLUSIONS: We conclude that younger patients and those with longer hospitalization stays may be more prone to C. difficile carriage. Studies of larger populations are warranted to clarify the exact role of C. difficile carriage in hospitalized cancer patients in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2334-14-523) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4261591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42615912014-12-10 Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China Fang, Wei-Jia Jing, Da-Zhi Luo, Yun Fu, Cai-Yun Zhao, Peng Qian, Jiong Tian, Bing-Ru Chen, Xiao-Gang Zheng, Yu-Long Zheng, Yi Deng, Jing Zou, Wei-Hua Feng, Xue-Ren Liu, Fan-Long Mou, Xiao-Zhou Zheng, Shu-Sen BMC Infect Dis Research Article BACKGROUND: Clostridium difficile carriage has been considered as a potential source for the deadly infection, but its role in cancer patients is still unclear. We aimed to identify the clinical and immunological factors that are related to C. difficile carriage in Chinese cancer patients. METHODS: A total of 400 stool samples were collected from cancer patients who received chemotherapy in three hospitals of eastern China. Bacterial genomic DNA was extracted and two toxin genes (tcdA and tcdB) were detected. PCR ribotyping was performed using capillary gel electrophoresis. Concentrations of prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β) and interleukin-10 (IL-10) were measured using enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: Eighty-two (20.5%) samples were confirmed to be C. difficile-positive and positive for tpi, tcdA, and tcdB genes. The C. difficile-positive rates in patients with diarrhea and no diarrhea were 35% and 19.7%, respectively (p = 0.09). Patients who were younger than 50 years old and were hospitalized for at least 10 days had a C. difficile-positive rate as high as 35%. In contrast, patients who were older than 50 years old and were hospitalized for less than 10 days had a C. difficile-positive rate of only 12.7% (p = 0.0009). No association was found between C. difficile carriage and chemotherapy regimen, antibiotic drug use, or immunosuppressive mediators, such as prostaglandin E2 (PGE2), transforming growth factor beta (TGF-β), or interleukin-10 (IL-10). Twelve ribotypes of C. difficile were identified, but none of them belonged to ribotype 027. CONCLUSIONS: We conclude that younger patients and those with longer hospitalization stays may be more prone to C. difficile carriage. Studies of larger populations are warranted to clarify the exact role of C. difficile carriage in hospitalized cancer patients in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2334-14-523) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-29 /pmc/articles/PMC4261591/ /pubmed/25267108 http://dx.doi.org/10.1186/1471-2334-14-523 Text en © Fang et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Fang, Wei-Jia Jing, Da-Zhi Luo, Yun Fu, Cai-Yun Zhao, Peng Qian, Jiong Tian, Bing-Ru Chen, Xiao-Gang Zheng, Yu-Long Zheng, Yi Deng, Jing Zou, Wei-Hua Feng, Xue-Ren Liu, Fan-Long Mou, Xiao-Zhou Zheng, Shu-Sen Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title | Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title_full | Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title_fullStr | Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title_full_unstemmed | Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title_short | Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China |
title_sort | clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261591/ https://www.ncbi.nlm.nih.gov/pubmed/25267108 http://dx.doi.org/10.1186/1471-2334-14-523 |
work_keys_str_mv | AT fangweijia clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT jingdazhi clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT luoyun clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT fucaiyun clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT zhaopeng clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT qianjiong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT tianbingru clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT chenxiaogang clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT zhengyulong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT zhengyi clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT dengjing clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT zouweihua clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT fengxueren clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT liufanlong clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT mouxiaozhou clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina AT zhengshusen clostridiumdifficilecarriageinhospitalizedcancerpatientsaprospectiveinvestigationineasternchina |